Artivion (AORT) Return on Capital Employed (2011 - 2026)
Artivion (AORT) posted Return on Capital Employed of 4.72% for Q1 2026, up 7.77% on a QoQ basis from 4.38% in Q4 2025, and up 260.0% year-over-year from 1.31% in Q1 2025.
Artivion (AORT) Return on Capital Employed (2011 - 2026) Analysis & Trends
Artivion's Return on Capital Employed history runs 16 years deep, the most recent figure standing at 4.72% for Q1 2026.
- Quarterly Return on Capital Employed rose 260.0% year-over-year to 4.72% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.72% (up 260.0% YoY) and the FY2025 annual result came in at 4.59%, down 78.0% from the prior year.
- Return on Capital Employed was 4.72% for Q1 2026 at Artivion, up from 4.38% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 6.12% in Q3 2024 and bottomed at 1.03% in Q3 2022.
- A 5-year average of 2.51% and a median of 2.13% in 2025 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2022 — Return on Capital Employed sank 360 bps — and 2024, when it soared 519 bps.
- Artivion's Return on Capital Employed stood at 0.88% in 2022, then dropped by 10 bps to 0.79% in 2023, then jumped by 574 bps to 5.33% in 2024, then declined by 18 bps to 4.38% in 2025, then grew by 8 bps to 4.72% in 2026.
- Business Quant data shows AORT's Return on Capital Employed at 4.72% in Q1 2026, 4.38% in Q4 2025, and 3.38% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.32 Bn | 177.02 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 68.65 Bn | 67.20 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 47.43 Bn | 43.76 Bn | 1.29 Bn | 11.13% |
| 6 | GE HealthCare Technologies | 28.48 Bn | 26.19 Bn | 1.98 Bn | 9.30% |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | 24.24% |
| 8 | Smith & Nephew | 26.98 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | 8.38% |
| 10 | Artivion | 1.25 Bn | 1.19 Bn | 75.45 Mn | 4.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.72% |
| Dec 31, 2025 | 4.38% |
| Sep 30, 2025 | 3.38% |
| Jun 30, 2025 | 2.35% |
| Mar 31, 2025 | 2.13% |
| Dec 31, 2024 | 5.33% |
| Sep 30, 2024 | 6.12% |
| Jun 30, 2024 | 4.58% |
| Mar 31, 2024 | 4.70% |
| Dec 31, 2023 | 0.79% |
| Sep 30, 2023 | 0.93% |
| Jun 30, 2023 | 0.54% |
| Mar 31, 2023 | 0.10% |
| Dec 31, 2022 | 0.88% |
| Sep 30, 2022 | -1.03% |
| Jun 30, 2022 | 1.58% |
| Mar 31, 2022 | 1.12% |
| Dec 31, 2021 | 1.07% |
| Sep 30, 2021 | 2.57% |
| Jun 30, 2021 | 1.12% |